Phathom Pharmaceuticals Inc

NASDAQ:PHAT 4:00:00 PM EDT

9.59

-0.15 (-1.54%)

6:45:49 PM EDT: $9.81 +0.22 (+2.29%)

Market Cap (Intraday)	669.52M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$36.38 Million
Adjusted EPS	-$0.91

See more estimates

10-Day MA	$9.58
50-Day MA	$5.73
200-Day MA	$8.89

See more pivots

Phathom Pharmaceuticals Inc Stock, NASDAQ:PHAT

100 Campus Drive, Suite 102, Florham Park, New Jersey 07932

United States of America

Phone: +1.877.742.8466

Number of Employees: 427

http://www.phathompharma.com

Description

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.